Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calciflex is a line of nutritional supplements developed by Primus Remedies, primarily formulated with calcium and vitamin D3 (cholecalciferol) to support bone health and joint function. The product line includes several formulations, such as Calciflex OS (calcium carbonate and cholecalciferol), Calciflex D (calcium citrate, magnesium, zinc, and cholecalciferol), and Calciflex XT (calcium carbonate, calcitriol, cyanocobalamin, and folic acid). These supplements are designed to address calcium and vitamin D deficiencies, enhance bone mineral density, and manage conditions like osteoporosis, particularly in elderly, pregnant, or lactating populations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Calciflex.